Table 2. Patient characteristics: Acarbose-free vs acarbose.
Characteristic | Acarbose-free group | Acarbose group | P |
---|---|---|---|
Patients, n | 215 | 89 | - |
Age, years | 54.8±10.4 | 54.2±12.5 | 0.439 |
Males, n (%) | 113 (52.6) | 52 (58.4) | 0.377 |
Fasting plasma glucose, mmol/L | 9.62±3.77 | 9.99±4.48 | 0.585 |
Postprandial plasma glucose, mmol/L | 18.70±5.78 | 17.51±7.34 | 0.301 |
HbA1c, mmol/mol | 72.68±1.31 | 70.93±2.51 | 0.584 |
HbA1c, % | 8.80±2.27 | 8.64±2.38 | 0.584 |
Fructosamine, mmol/L | 361.4±103.4 | 386.95±118.06 | 0.126 |
Chronic complications, n (%) | 142 (66.0) | 44 (49.4) | <0.01 |
Acute complications, n (%) | 10 (4.7) | 3 (3.4) | 0.762 |
Hypoglycemia medications, n (%) | |||
Insulin | 51 (23.7%) | 11 (12.4%) | >0.05 |
Oral | 112 (52.1%) | 57 (64.0%) | |
Both | 52 (24.2%) | 21 (23.6%) |
Data are presented as mean ± SD, number, or percentage
P values were calculated using Student’s t t test or χ2 test